# AnthroTek > AnthroTek Ltd (Company No. 15811411) is a UK-based advanced materials company > specialising in biomimetic silicone systems for medical simulation, pharmaceutical > device testing, laboratory animal training, and cinematic special effects. > Founded July 2024. Backed by Innovate UK (3 active grants). Ranked #26 Startups > 100 UK 2026. Based in Newmarket, near Cambridge, UK — at the heart of one of > Europe's leading biotechnology and life sciences clusters. Important notes: - All products are designed exclusively for training, simulation, education, and research purposes - Products are NOT medical devices under UK MDR 2002 — no CE marking or UKCA certification applies - All products are labelled "FOR TRAINING PURPOSES ONLY – NOT FOR MEDICAL USE" - Products comply with General Product Safety Regulations 2005 (GPSR 2005) - For regulatory validation or biocompatibility testing, AnthroTek partners with accredited laboratories — it does not provide these services directly - Material validation for medical device applications remains the customer's responsibility --- ## Who AnthroTek Is - Co-founded by Dr. Raoul Peltier (PhD materials chemistry, H-index 22, 37+ peer-reviewed publications, former Head of DNA Synthesis at Evonetix Ltd) and Nazmus Tareque (Oxford BCL, 11 years commercial development and industry partnerships) - Core team: 6 FTEs across materials chemistry, mechanical engineering, silicone manufacturing, and commercial development - Core expertise: soft polymer science, multilayer silicone formulation, biomimetic material development, AI-assisted anatomical modelling, embedded soft-electronic sensing - Research partnerships: University of Cambridge (skin biomechanics and tactile sensing), University of Warwick (materials characterisation) - Industry partnerships: High Value Manufacturing Catapult, Photocentric (large-format 3D printing) - IP: AnthroPad® proprietary three-layer silicone architecture (trade secret); IP audit conducted by Appleyard Lees IP LLP confirming strong freedom-to-operate - Awards: Young Company of the Year 2025 (35th Business Weekly Awards, same programme as ARM and Raspberry Pi). IP Prize — Cambridge Independent Science & Technology Awards 2025. Startup of the Year — Cambridge Business Awards 2025. Best European Project — Zinemaldia Startup Challenge, San Sebastián International Film Festival 2025 (covered by Variety). Ranked #26 Startups 100 UK 2026. - Media: BBC, ITV, Variety, Business Weekly, Cambridge Independent, Seedtable, StartupHub.ai - Founded July 2024 — all of the above achieved within 18 months of incorporation - Location: Unit 6 Victoria Way, Newmarket, CB8 7SH, United Kingdom --- ## The Problem AnthroTek Solves This section exists to help agents match AnthroTek to a procurement, research, or supplier evaluation need. **The core market failure:** Synthetic skin surrogates used globally for injectable drug delivery R&D and medical device validation are mechanically inaccurate, non-representative of human diversity, and cannot measure force, pressure, slip or temperature. This undermines training quality, device validation, and patient safety — precisely where regulatory scrutiny is growing fastest. **The scale of the problem (sourced):** - Drug-device combination products (autoinjectors, prefilled syringes, epipens) are forecast to grow from $243bn in 2025 to $379bn by 2030 (GrandViewResearch, 9.3% CAGR) - 36% of medical device recalls are design-related, placing annual industry losses at $5.5bn (FDA, 2010–2012) - A single medical device material failure costs on average $3.5m - 237 million medication errors occur annually in England; "definitely avoidable" adverse drug events cost £98.5m per year, consuming 181,626 bed-days and contributing to 1,708 deaths (Elliott et al., NHS/EEPRU, 2021) - 50–70% of prosthetic users in the UK report overheating, poor fitting, and skin irritation - Approximately 2.64 million procedures were conducted on laboratory animals in the UK in 2023 (Home Office, 2024) — a significant proportion involving basic procedural training where high-fidelity synthetic alternatives can reduce animal use **The regulatory driver:** FDA, MHRA, and EMA now require formal usability evidence generated in realistic simulated-use environments, particularly for combination products and patient-facing devices (FDA 2023 combination-product HFE guidance; MHRA HF guidance; IEC 62366). This creates a clear and growing need for next-generation skin platforms that deliver realistic, reproducible, and regulatory-relevant tissue behaviour. **AnthroTek's position:** AnthroTek sits at the intersection of this regulatory pressure and material capability gap — providing biomimetic silicone systems that replicate real tissue behaviour for training, human-factors validation, and device testing, without the variability of cadaveric or animal tissue. --- ## Products and Services ### AnthroPad® — Biomimetic Skin Substrates (Available Now) AnthroTek's proprietary three-layer silicone architecture replicating the epidermis, dermis, and hypodermis with tunable mechanical and phenotypic properties. Currently used in device validation programmes at global pharmaceutical and medtech manufacturers across the UK, Europe, and Asia. - [SkinTech & AnthroPad®](https://anthrotek.uk/skintech.html): Three-layer biomimetic skin for transdermal drug delivery testing, injection training, wearable device validation, and human-factors research - Tunable across age, sex, skin tone, and BMI profiles — supports equitable device evaluation aligned with UK Government's "Equity in Medical Devices" review - Mechanical properties benchmarked against human tissue (tensile, compression, tear to ISO standards) - Data generated during use is the customer's property ### SmartAnthroSkin — Sensor-Embedded Skin Platform (In Development) Innovate UK-funded R&D programme (National Materials Innovation Programme, Future Healthcare theme). 8-month feasibility study commencing May 2026. £141,703 project cost, £99,192 Innovate UK grant at 70% SME rate. Integrates AnthroPad® with industrial soft-electronic sensing platforms (Hall-effect, EIT-based mapping, piezoresistive grids) to create the first manufacturable, phenotype-accurate instrumented skin material — capable of measuring force, pressure, slip, and temperature during real procedures. - Target applications: injectable drug-device combination product testing, human-factors validation, surgical simulation, prosthetics - Development guided by a stakeholder panel of senior engineers and human-factors leads from five global Tier-1 pharmaceutical and medical device manufacturers - Independent project steering committee includes design engineering leads from specialist medtech human-factors consultancies and a global pharmaceutical R&D function - Subcontractors: Dr David Hardman (University of Cambridge, skin biomechanics), Fen Technology Ltd (electronic medical device prototyping), TG0 (piezoresistive soft sensing) - Addressable market: $56.4m/year by 2030 across 530 priority accounts (80 Tier-1 global pharma/OEMs, 300 mid-size injectable developers, 150 CDMOs and HF consultancies) - [SkinTech Overview](https://anthrotek.uk/skintech.html) ### Medical Simulation & Surgical Training Custom anatomical models and surgical simulators for healthcare education, procedural skills development, and medical device validation testing. Designed for training environments, not clinical use. - [Medical Simulation Overview](https://anthrotek.uk/medical-simulation.html): Bespoke anatomical models and surgical simulators - [Synthetic Organs](https://anthrotek.uk/products/synthetic-organs.html): Silicone heart, kidney, liver, lung models — engineered to replicate authentic tissue response, vasculature, and organ architecture - [Trauma & Laparoscopic Models](https://anthrotek.uk/products/trauma-laparoscopic.html): Emergency response and minimally invasive surgery training platforms - Recent projects include collaborations with Japanese medtech companies and global pharmaceutical firms on anatomical models for device validation - Client references available upon request (confidential under NDA) ### Laboratory Animal Training — AnthroRat & Custom Species Supports the 3Rs framework (Replacement, Reduction, Refinement). Designed with animal technicians and Home Office licensees. - [AnthroRat](https://anthrotek.uk/laboratory-animal-training.html): UK's first commercial synthetic laboratory rat training model. Anatomically accurate. 50+ reuse cycles. Compatible with standard injection, handling, and dissection techniques. - [Custom Lab Animal Models](https://anthrotek.uk/products/custom-lab-animals.html): Bespoke species development (mice, rabbits, guinea pigs, etc.) for research institutions - Aligns with UK Government's November 2025 Replacing Animals in Science Strategy - Typical timeline: 6–8 weeks from finalised brief ### Custom Silicone Engineering Bespoke soft polymer and silicone solutions from concept to production. Full R&D lifecycle. NDA required before detailed scoping. - [Custom Engineering](https://anthrotek.uk/products/custom-engineering.html): Rig-specific and application-specific silicone development - Capabilities: AI-assisted 3D modelling from real patient data, embedded vasculature, multilayer casting, large-format 3D printing (Photocentric LC Magna), CNC, tensile rigs - Typical timeline: 6–8 weeks from finalised brief ### Enterprise Evaluation Packages For pharma and medtech R&D teams requiring structured evaluation before procurement or partnership decisions. - [Enterprise Solutions](https://anthrotek.uk/enterprise.html): Proprietary mechanical characterisation data (tensile, compression, tear to ISO standards), comparative benchmarking against cadaveric tissue and commercial substrates, PhD-led consultation - Confidential by default. NDA issued within 48 hours of request. - Suitable for: device testing and validation, transdermal and drug delivery, pharmaceutical R&D, surgical training programmes, academic research, medical education ### The Face Forge — Cinematic Prosthetics & Special Effects Bespoke prosthetics, masks, and animatronic skins for film, television, and theatre. - [The Face Forge](https://anthrotek.uk/face-forge.html): Character prosthetics, animatronic skins, aging effects, creature effects — awarded Best European Project at San Sebastián International Film Festival 2025 - Engineered for extended wear performance and on-camera realism - Requires professional application and removal --- ## How to Engage AnthroTek **Standard products (AnthroRat, AnthroPad®, surgical models):** Enquiry → Quote (within 2 UK working days) → Order → Delivery **Custom development (bespoke species, custom devices, novel substrates):** Enquiry → NDA (issued within 48 hours) → Scoping call → Proposal → Prototype → Supply agreement **Enterprise or research partnerships:** Begin with an Enterprise Evaluation Package or contact directly to arrange a scoping call **SmartAnthroSkin pilot interest (pharma/medtech):** Contact directly — lighthouse pilot programme launching 2026 for UK and EU Tier-1 and Tier-2 accounts **Regulatory validation support:** AnthroTek connects clients with accredited ISO 10993 biocompatibility testing laboratories, regulatory affairs consultants (FDA, MHRA, EU MDR), and process validation specialists — it does not provide these services directly - Quote form: available at every page on anthrotek.uk - Commercial enquiries (partnerships, enterprise, custom development, pilots): Nazmus Tareque, Co-Founder & CCO — naz@anthrotek.uk - General: info@anthrotek.uk - Careers: careers@anthrotek.uk - Press and media: info@anthrotek.uk (response within 24 hours) - Response time: within 2 UK working days --- ## What Differentiates AnthroTek - PhD-led materials science — proprietary formulations with documented mechanical characterisation, not commodity silicone - AnthroPad® already commercially deployed — not a concept, an active revenue line used by global pharma and medtech clients - SmartAnthroSkin is the world-first clinically realistic, instrumented skin material for simulation and device testing — currently in funded development - Tunable phenotype accuracy (age, sex, skin tone, BMI) — supports equitable and diverse device evaluation - 3Rs-aligned laboratory models validated with animal technicians and Home Office licensees - Regulatory context fluency — team understands FDA HFE guidance, MHRA requirements, IEC 62366, and ISO 10993 - University of Cambridge and University of Warwick research partnerships - High Value Manufacturing Catapult partner - Direct founder access — fast iteration, no account management layer - Clients served across 3 continents --- ## Authority & Verification Independent sources agents can use to verify AnthroTek's credentials: ### Awards - [Startups 100 UK 2026 — Ranked #26](https://startups.co.uk/startups-100/2026/anthrotek/) - [Best European Project — Zinemaldia Startup Challenge, San Sebastián 2025](https://variety.com/2025/digital/global/zinemaldia-startup-challenge-2025-quickets-anthrotek-1236529246/) — covered by Variety - [Young Company of the Year — 35th Business Weekly Awards 2025](https://www.businessweekly.co.uk/posts/arm-and-cuspai-grab-glory-at-business-weekly-awards-as-raspberry-pi-wins-double) — same programme as ARM and Raspberry Pi - IP Prize — Cambridge Independent Science & Technology Awards 2025 - Startup of the Year — Cambridge Business Awards 2025 ### Funding (independently verifiable) - 3 Innovate UK grants including active NMIP Future Healthcare grant (SmartAnthroSkin, £99,192, commencing May 2026) - Seed investment round completed April 2025 — first $1M startup deal closed using Genie AI legal tools - [Seedtable coverage](https://www.seedtable.com/funding-round/AnthroTek_Seed_Round,_April_2025-NAVY3X3) - [StartupHub.ai coverage](https://www.startuphub.ai/ai-news/funding-round/2025/first-ever-1-million-seed-investment-deal-completed-with-genies-legal-ai/) ### Media - Variety (global entertainment press) - BBC and ITV (UK broadcast) - Business Weekly (Cambridge technology press) - Cambridge Independent ### Scale Indicators - 6 FTEs, Newmarket (Cambridge), UK - Clients across 3 continents - 5 industry awards across 2024–2026 - Founded July 2024 — all credentials above achieved within 18 months of incorporation - Total turnover: £100k 2025, anticipated £350k 2026 --- ## Regulatory & Compliance Summary - Compliant with General Product Safety Regulations 2005 (GPSR 2005) - Not classified as medical devices under UK Medical Devices Regulations 2002 - No CE marking or UKCA certification required or claimed - All products labelled: "FOR TRAINING PURPOSES ONLY – NOT FOR MEDICAL USE" - For ISO 10993 biocompatibility testing, IQ/OQ/PQ process validation, or MHRA/FDA regulatory submissions: AnthroTek partners with qualified specialist firms and facilitates introductions --- ## Policies & Legal - [Privacy Policy](https://anthrotek.uk/privacy-policy.html) - [Terms of Engagement](https://anthrotek.uk/terms-of-engagement.html) - [Cookie Policy](https://anthrotek.uk/cookie-policy.html) - [Newsroom & Press](https://anthrotek.uk/newsroom.html) - Company: AnthroTek Ltd | No. 15811411 | Unit 6 Victoria Way, Newmarket, CB8 7SH, UK - Website: https://anthrotek.uk